GGrantIndex
Sort

78,016 grants matching breast cancer

Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment

$617,373
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2019 · CA

(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care

$617,350
Ann B. Nattinger · Medical College Of Wisconsin · R01 · FY2017 · CA

Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors

$617,348
Anita Y Kinney · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA

Hormonal Regulation of Breast Cancer

$617,319
Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2020 · CA

Cell cycle paths as a framework for understanding drug resistance in tumor cell subpopulations

$617,314
Jeremy Purvis · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Mechanisms of actin filament remodeling and disassembly

$617,276
Bruce L Goode · Brandeis University · R01 · FY2017 · GM

Mechanisms of actin filament remodeling and disassembly

$617,276
Bruce L Goode · Brandeis University · R01 · FY2019 · GM

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$617,257
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy

$617,228
Craig Lewis Duvall · Vanderbilt University · R01 · FY2021 · CA

Project 1

$617,225
Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2014 · CA

Functional Analysis of Human Breast Cancer Susceptibility Gene Variants

$617,157
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

HIFU-immunotherapy in pancreatic cancer

$617,146
Katherine W Ferrara · Stanford University · R01 · FY2022 · CA

Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia

$617,101
John Eisenbrey · Thomas Jefferson University · R01 · FY2020 · EB

Identification of human tumor-associated antigens

$617,092
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Analyses of human T regulatory cells

$617,092
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Improving Patient Outcomes Through System Navigation

$617,061
Peter C Raich · Denver Health And Hospital Authority · U01 · FY2006 · CA

The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities

$617,044
Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2021 · CA

Perfluoroalkyl Substances and the Gut Microbiome and Fecal Metabolome: Implications for Obesity Risk in Hispanic Children

$617,027
Tanya Lynn Alderete · Johns Hopkins University · R01 · FY2024 · ES

Tumor gene expression in vitro and in vivo

$617,011
Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis

$617,010
John Alan Shepherd · University Of Hawaii At Manoa · R01 · FY2023 · CA

Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms

$616,954
Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA

ICON TARGETING OF TUMOR VASCULATURE AND TUMOR CELLS

$616,916
Albert B Deisseroth · Sidney Kimmel Cancer Center · P01 · FY2007 · CA

Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection

$616,815
Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2021 · AI

Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology

$616,764
Nicole Franziska Steinmetz · Case Western Reserve University · U01 · FY2017 · CA

Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy

$616,715
Betty Kim · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA